The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $23,000,000 in first-year total cost, median $11,500,000.
Most frequent study sections
- Special Emphasis Panel[ZAI1 ZL-M (J1)]2
Most frequent institutions
- BOSTON UNIVERSITY MEDICAL CAMPUS1
- UNIVERSITY OF TEXAS MED BR GALVESTON1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trial Not Allowed)2UC7AI094660-11 | KOBINGER, GARY | UNIVERSITY OF TEXAS MED BR GALVESTON, TX | $11,500,000 | ZAI1 |
| 2021 | National Emerging Infectious Diseases Laboratories Operations2UC7AI095321-08 | CORLEY, RONALD B | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $11,500,000 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.